Cargando…

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

The COVID-19 pandemic has underscored the critical need for broad-spectrum therapeutics against respiratory viruses. Respiratory syncytial virus (RSV) is a major threat to pediatric patients and the elderly. We describe 4′-fluorouridine (4′-FlU, EIDD-2749), a ribonucleoside analog that inhibits RSV,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sourimant, Julien, Lieber, Carolin M., Aggarwal, Megha, Cox, Robert M., Wolf, Josef D., Yoon, Jeong-Joong, Toots, Mart, Ye, Chengin, Sticher, Zachary, Kolykhalov, Alexander A., Martinez-Sobrido, Luis, Bluemling, Gregory R., Natchus, Michael G., Painter, George R., Plemper, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206510/ https://www.ncbi.nlm.nih.gov/pubmed/34855509 http://dx.doi.org/10.1126/science.abj5508

Ejemplares similares

4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses
por: Lieber, Carolin M., et al.
Publicado: (2023)

Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
por: Sourimant, Julien, et al.
Publicado: (2022)

Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020)

Analysis of the Potential for N(4)-Hydroxycytidine To Inhibit Mitochondrial Replication and Function
por: Sticher, Zachary M., et al.
Publicado: (2020)

SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
por: Lieber, Carolin M., et al.
Publicado: (2022)

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
por: Cox, Robert M., et al.
Publicado: (2023)

Progress and pitfalls of a year of drug repurposing screens against COVID-19()
por: Sourimant, Julien, et al.
Publicado: (2021)

Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity
por: Cox, Robert M., et al.
Publicado: (2021)

Next-generation direct-acting influenza therapeutics
por: Toots, Mart, et al.
Publicado: (2020)

Small-Molecule Antiviral β-d-N(4)-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
por: Agostini, Maria L., et al.
Publicado: (2019)

Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex
por: Sourimant, Julien, et al.
Publicado: (2016)

ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
por: Squires, Katherine E., et al.
Publicado: (2020)

Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding
por: Wittwer, Kevin, et al.
Publicado: (2021)

Viral evolution identifies a regulatory interface between paramyxovirus polymerase complex and nucleocapsid that controls replication dynamics
por: Sourimant, Julien, et al.
Publicado: (2020)

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
por: Painter, George R, et al.
Publicado: (2021)

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
por: Wu, Debra, et al.
Publicado: (2021)

Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M(pro) Inhibitors
por: Jacobs, Leon, et al.
Publicado: (2023)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition
por: Aggarwal, Megha, et al.
Publicado: (2020)

Dye label interference with RNA modification reveals 5-fluorouridine as non-covalent inhibitor
por: Spenkuch, Felix, et al.
Publicado: (2014)

Enhanced Antitumor Effect of 5′‐Deoxy‐5‐fluorouridine by Oral Administration with l‐Cysteine
por: Iigo, Masaaki, et al.
Publicado: (1989)

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
por: Palomar-Siles, Mireia, et al.
Publicado: (2022)

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
por: Sheahan, Timothy P., et al.
Publicado: (2020)

Simple In Vitro Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5′-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA Polymerase
por: Lu, Gaofei, et al.
Publicado: (2018)

A High-Content, Phenotypic Screen Identifies Fluorouridine as an Inhibitor of Pyoverdine Biosynthesis and Pseudomonas aeruginosa Virulence
por: Kirienko, Daniel R., et al.
Publicado: (2016)

Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses
por: Brinton, Margo A, et al.
Publicado: (2019)

Interferon-α Enhances 5′-Deoxy-5-Fluorouridine-Induced Apoptosis by ERK-Dependant Upregulation of Thymidine Phosphorylase
por: Zhu, Yike, et al.
Publicado: (2013)

Antitumor Effects of 5′‐Deoxy‐S‐fluorouridine in Combination with Recombinant Human Interleukin 2 on Murine Colon Carcinoma 26
por: Midoro, Katsuo, et al.
Publicado: (1997)

Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases
por: Krumm, Stefanie A., et al.
Publicado: (2011)

Editorial overview: Special issue on antiviral strategies in Current Opinion in Virology
por: Plemper, Richard K
Publicado: (2021)

The Cell Cycle Timing of Human Papillomavirus DNA Replication
por: Reinson, Tormi, et al.
Publicado: (2015)

Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study.
por: Ahn, M. J., et al.
Publicado: (1998)

The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells
por: Toots, Mart, et al.
Publicado: (2014)

The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer
por: Yoshimoto, M, et al.
Publicado: (2003)

Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2′-deoxy-5-fluorouridine into DNA
por: SAKAMOTO, KAZUKI, et al.
Publicado: (2015)

Enhancement of the Anti‐tumor Effect of 5′‐Deoxy‐5‐fluorouridine by Transfection of Thymidine Phosphorylase Gene into Human Colon Cancer Cells
por: Kanyama, Hiroki, et al.
Publicado: (1999)

Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine
por: Ninomiya, Yasuyuki, et al.
Publicado: (1990)

5′‐Deoxy‐S‐fluorouridine Increases Daunorubicin Uptake in Multidrug‐resistant Cells and Its Activity Is Related with P‐gp 170 Expression
por: van der Heyden, Sylke, et al.
Publicado: (1994)

Visualizing the replication of respiratory syncytial virus in cells and in living mice
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2014)

Structure of the Respiratory Syncytial Virus Polymerase Complex
por: Gilman, Morgan S.A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uhsorkti5a66v27manvni5ik9q